HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
54 hedge funds and large institutions have $437M invested in HilleVax in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 11 closing their positions.
222% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 9
0% more capital invested
Capital invested by funds: $436M → $437M (+$400K)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2.47% less ownership
Funds ownership: 67.28% → 64.81% (-2.5%)
11% less funds holding
Funds holding: 61 → 54 (-7)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$7.68M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.39M |
| 3 |
BlackRock
New York
|
+$3.61M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$3.31M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$29.1M |
| 2 |
PA
Perceptive Advisors
New York
|
-$6.71M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$5.75M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$4.11M |
| 5 |
HF
HRT Financial
New York
|
-$297K |
HLVX Hedge Fund Activity: Q2 2023 in Review
54 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q2 2023, worth a combined $437M — up 0.09% from $436M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of HLVX and 5 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 29 added.
The largest buyer was Deerfield Management, adding an estimated $7.68M. The largest seller was RA Capital Management, exiting entirely with an estimated $29.1M sold.
- 54 institutional investors held HilleVax (HLVX) as of Q2 2023, down from 61 in Q1 2023.
- Funds reported $437M of HilleVax stock for Q2 2023, up 0.09% quarter-over-quarter.
- 5 funds opened new HilleVax positions in Q2 2023 and 11 closed out, a net change of -6 holders.
- The largest HilleVax buyer in Q2 2023 was Deerfield Management, an estimated $7.68M added.
- The largest HilleVax seller in Q2 2023 was RA Capital Management, an estimated $29.1M sold.
Based on aggregated 13F filings for Q2 2023.